Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) McMurray, J. J., Wheeler, D. C., Stefansson, B. V., Rotter, R., Chertow, G. M., Greene, T., Hou, F., Lindberg, M. B., Rossing, P., Sjostrom, D., Toto, R. D., Langkilde, A., Heerspink, H., DAPA-CKD Comm Investigators LIPPINCOTT WILLIAMS & WILKINS. 2020: E482–E483

View details for Web of Science ID 000639226400043